Latest News of ZURA
Sage Therapeutics/Biogen's episodic therapy zuranolone could change MDD treatment
By Yahoo! Finance |
2 months ago
Sage Therapeutics and Biogen's zuranolone, a novel antidepressant for MDD, showed positive results in a Phase III trial. The drug's rapid response treatment offers a new mechanism of action in a compe...
Zura Bio Shares Fall on Warrant Exchange Offer to Simplify Capital Structure
By MarketWatch |
2 months ago
Zura Bio's shares declined as the company initiated a warrant exchange offer to simplify its capital structure and reduce dilution. The stock fell 2.9% to $3.64, down 22% year-to-date and 42% in the p...